Because of the role of Ca2+ in apoptosis, it has been proposed that cancer cells early in progression may find advantage in minimizing SOCE, while later in progression after inactivation of apoptotic signaling by p53, they may upregulate Ca2+ influx to benefit from its metabolic and mitogenic effects [51]. The gene discussed is TP53; the disease is cancer.